101 related articles for article (PubMed ID: 22439750)
1. Quaternary structure, aggregation and cytotoxicity of transthyretin.
Mizuguchi M; Yokoyama T; Nabeshima Y; Kawano K; Tanaka I; Niimura N
Amyloid; 2012 Jun; 19 Suppl 1():5-7. PubMed ID: 22439750
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tomoyori K; Tanaka I; Niimura N
J Struct Biol; 2012 Feb; 177(2):283-90. PubMed ID: 22248451
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-bond network and pH sensitivity in human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tanaka I; Niimura N
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):834-7. PubMed ID: 24121323
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.
Lei M; Yang M; Huo S
J Struct Biol; 2004 Nov; 148(2):153-68. PubMed ID: 15477096
[TBL] [Abstract][Full Text] [Related]
6. Stability and crystal structures of His88 mutant human transthyretins.
Yokoyama T; Hanawa Y; Obita T; Mizuguchi M
FEBS Lett; 2017 Jul; 591(13):1862-1871. PubMed ID: 28563699
[TBL] [Abstract][Full Text] [Related]
7. Mutation and low pH effect on the stability as well as unfolding kinetics of transthyretin dimer.
Xue Q; Zheng QC; Zhang JL; Cui YL; Chu WT; Zhang HX
Biophys Chem; 2014 May; 189():8-15. PubMed ID: 24632442
[TBL] [Abstract][Full Text] [Related]
8. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
Lai Z; Colón W; Kelly JW
Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin.
Hörnberg A; Eneqvist T; Olofsson A; Lundgren E; Sauer-Eriksson AE
J Mol Biol; 2000 Sep; 302(3):649-69. PubMed ID: 10986125
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.
Sebastião MP; Lamzin V; Saraiva MJ; Damas AM
J Mol Biol; 2001 Mar; 306(4):733-44. PubMed ID: 11243784
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Castro-Rodrigues AF; Gales L; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2011 Dec; 67(Pt 12):1035-44. PubMed ID: 22120741
[TBL] [Abstract][Full Text] [Related]
12. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
Sekijima Y; Dendle MT; Wiseman RL; White JT; D'Haeze W; Kelly JW
Amyloid; 2006 Jun; 13(2):57-66. PubMed ID: 16911959
[TBL] [Abstract][Full Text] [Related]
13. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
[TBL] [Abstract][Full Text] [Related]
14. Dimeric transthyretin variant assembles into spherical neurotoxins.
Matsubara K; Mizuguchi M; Igarashi K; Shinohara Y; Takeuchi M; Matsuura A; Saitoh T; Mori Y; Shinoda H; Kawano K
Biochemistry; 2005 Mar; 44(9):3280-8. PubMed ID: 15736938
[TBL] [Abstract][Full Text] [Related]
15. The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
Zhang F; Hu C; Dong Y; Lin MS; Liu J; Jiang X; Ge Y; Guo Y
Arch Biochem Biophys; 2013 Jul; 535(2):120-7. PubMed ID: 23523753
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
Hurshman Babbes AR; Powers ET; Kelly JW
Biochemistry; 2008 Jul; 47(26):6969-84. PubMed ID: 18537267
[TBL] [Abstract][Full Text] [Related]
17. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
Wiseman RL; Green NS; Kelly JW
Biochemistry; 2005 Jun; 44(25):9265-74. PubMed ID: 15966751
[TBL] [Abstract][Full Text] [Related]
18. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
[TBL] [Abstract][Full Text] [Related]
19. Prevention of transthyretin amyloid disease by changing protein misfolding energetics.
Hammarström P; Wiseman RL; Powers ET; Kelly JW
Science; 2003 Jan; 299(5607):713-6. PubMed ID: 12560553
[TBL] [Abstract][Full Text] [Related]
20. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.
Foss TR; Kelker MS; Wiseman RL; Wilson IA; Kelly JW
J Mol Biol; 2005 Apr; 347(4):841-54. PubMed ID: 15769474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
